Trump calls for lawsuit against some opioid companies - Action News
Home WebMail Wednesday, November 20, 2024, 10:43 AM | Calgary | -10.2°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Health

Trump calls for lawsuit against some opioid companies

Trump administration also wants to cut production quotas of most-abused opioids, including oxycodone and fentanyl.

Many U.S. states and cities are already suing drug manufacturers

A pill is shown crumbled in half.
On Thursday, U.S. President Donald Trump said he wanted to file a federal lawsuit against certain companies that supply and manufacture opioids, rather than joining existing lawsuits filed by several states. (CBC)

U.S. President Donald Trump is asking Attorney General Jeff Sessions to file a federal lawsuit against certain companies that supply and manufacture opioids.

Speaking during a Cabinet meeting Thursday, Trump said he's directing Sessions to file a separate lawsuit, rather than joining existing lawsuits filed by states affected by the spread of the often-lethal, highly addictive drugs.

Trump is asking Sessions to look out for opioids coming into the U.S. from China and Mexico, saying those countries are "sending their garbage and killing our people."

Trump added: "It's almost a form of warfare."

It was not immediately clear if or when a federal suit would be filed. A barrage of suits have been filed nationwide against distributors and manufacturers in recent months amid the opioid epidemic.

On Thursday, the Trump administration also said itwas proposing that U.S. pharmaceutical companies cut production of the six most abused opioids by 10 per cent next year, in an effort to reduce the number of drugs potentially diverted for trafficking.

In a joint statement, the U.S. Justice Department and Drug Enforcement Administration said the proposed reduction would be in keeping with Trump's effort to cut opioid prescription fills by one-third within three years.

The agencies said they are proposing to cut production quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, and fentanyl by sevenper cent to 15 per cent in 2019.

With files from Reuters